Jupiter Neurosciences, Inc. Warrants (JUNSW)
$0.00
$--
(--%)
As on 08-Feb-2022EDT
Market cap
$-- Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-- Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
-0
-
Book Value
$--
-
EPS
$-0.1
-
Face value
--
-
Shares outstanding
0
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
| -- | -- | -- | -- | -- | -- | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.4 | 4.5 | 5.3 | 10.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
0.0 | -- | 1.1 | -1.7 | -- | 37.9 | -- | 0.0 |
| 13.5 | 846.5 | 0.0 | -175.9 | -- | -106.8 | -- | 5.3 | |
| 14.1 | 2,449.0 | 549.1 | 17.9 | -6.3 | 1.4 | 140.9 | 1.7 | |
| 4.8 | 1,129.1 | 4.5 | -340.2 | -518.6 | 501.4 | -- | 2.1 | |
| 13.0 | 592.5 | 0.0 | -29.0 | 0.0 | -20.4 | -- | 2.0 | |
| 17.3 | 2,249.1 | 120.8 | -57.8 | -42.6 | -9.9 | -- | 3.9 | |
| 11.2 | 794.8 | 366.5 | 9.3 | 8.3 | 3.4 | 80.2 | 2.9 | |
| 3.7 | 671.1 | 4.1 | -187.9 | -4,613.1 | -233.9 | -- | 0.3 | |
| 14.6 | 906.8 | 0.6 | -60.0 | -9,892.6 | -119 | -- | 23.9 | |
| 26.2 | 2,944.7 | 449.6 | -188.2 | -41.1 | -28.5 | -- | 4.9 |
Shareholding Pattern
View DetailsAbout Jupiter Neurosciences, Inc. Warrants (JUNSW)
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the... treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida. Read more
-
Headquarters
--
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Jupiter Neurosciences, Inc. Warrants (JUNSW)
What is the current share price of Jupiter Neurosciences, Inc Warrants (JUNSW) Today?
The share price of Jupiter Neurosciences, Inc Warrants (JUNSW) is $0.00 (NASDAQ) as of 08-Feb-2022 EDT. Jupiter Neurosciences, Inc Warrants (JUNSW) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Jupiter Neurosciences, Inc Warrants (JUNSW)?
Since, TTM earnings of Jupiter Neurosciences, Inc Warrants (JUNSW) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2020 |
-- |
-- |
2019 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of Jupiter Neurosciences, Inc Warrants (JUNSW)?
The 52-week high and low of Jupiter Neurosciences, Inc Warrants (JUNSW) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of Jupiter Neurosciences, Inc Warrants (JUNSW)?
Jupiter Neurosciences, Inc Warrants (JUNSW) has a market capitalisation of -- as on 08-Feb-2022. As per SEBI classification, it is a company.
Should I invest in Jupiter Neurosciences, Inc Warrants (JUNSW)?
Before investing in Jupiter Neurosciences, Inc Warrants (JUNSW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.